RESEARCH SUMMARY
The following areas of research are currently being pursued in Dr. Sriram’s laboratory:
a) Using an animal model of LPS mediated demyelination, the laboratory is focusing on the particular neuroimaging characteristics of the demyelinating regions. In addition the research group is exploring novel neuroprotective strategies that will reverse the extent and severity of injury.
b) We are examining the role of the different isoforms of nitric oxide synthase in mediating mitochondrial injury in cultured oligodendrocytes that are cultured with different TLR agonists. We are also examining the role of key enzymes in mitochondrial respiratory chain proteins that mimic hypoxic damage following treatment of oligodendrocytes with LPS.
c) In patients receiving beta Interferon as a treatment for multiple sclerosis, we are examining the role of p53 and p53 down stream protein activation and regulation in lymphocyte populations of peripheral blood mononuclear cells.
d) In collaboration with Dr. Y. Tang and C. Stratton from the department of pathology, we are studying the expression of Chlamydial mRNA in spinal fluid of patients with early MS.
SELECTED PUBLICATIONS
Yao, S., Soutto, M., Sriram, S. Preconditioning with Cobalt chloride or Desferrioxamine Protects Oligodendrocyte Cell Line (MO3.13) from TNF alpha Mediated Cell Death. 2008. J. NeuroScience Res 208. 86:2403-2413.
Yao, S., Soutto, M., Sriram, S. Bacterial Cell Wall Products Increases Stabilization of HIF-1 alpha in an Oligodendrocyte cell line Preconditioned by Cobalt Chloride or Desferrioxamine. J. Neroimmunol. 2008. 30:17-26.
Pawate, S., Agarwal, A Moses, H., and Sriram, S. The Spectrum of Susac's Syndrome. J. Clin Neurology, 2009 Feb, 30(1):59-64.
Tang,Y.W., Sriram, S., Li, H., Yao, S., Meng, W., Mitchell, M., and Stratton, C.W. Qualitative and Quantitative Detection of Chlamydophila pneumoniae DNA in Cerebrospinal Fluid from Multiple Sclerosis Patients and Controls. 2009, 4(4):e5200.
Pawate, S., Moses, H. and Sriram, S. Neurosarcoidosis:
Presentations and Outcomes of Neurosarcoidosis: a study of 54 cases. 2009
Jul, 102(7):449-60.